NASDAQInformation TechnologyScientific & Technical InstrumentsSnapshot 2026-07-23
Reading CGNX? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with a focus on revenue growth and margin enhancement. The current thesis state is intact, supported by recent strong financial results.
The market seems to have priced in a premium compared to peers, indicating expectations for continued strong performance. However, the valuation is considered expensive, suggesting that some of the positive outlook may already be reflected in the current setup.
Management is on track with priorities to increase revenue growth, improve operating income, and enhance gross profit margins. While the near-term risk of missing earnings is low, there is a historical context of earnings surprises trending down.
The long-term thesis hinges on several factors, including the potential for the Federal Reserve to cut rates, which could benefit CGNX and the tech sector. Additionally, the performance of sector leaders like COHR, KEYS, and TDY will be crucial for maintaining momentum.
Overall, CGNX's strong fundamentals and management execution provide a solid foundation, but the high valuation and external economic factors introduce uncertainty. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. This improvement is driven by the latest earnings beat and above-expected guidance, which signals strong demand and boosts revenue growth. There are no significant threats currently impacting the thesis.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: This EPS guidance shows how well Cognex can manage costs. Higher EPS means better financial health.
Confirms:Q2 2026 adjusted EPS guidance confirmed at $0.40 or higher.
Disproves:Q2 2026 adjusted EPS guidance below $0.40.
Why it matters: Better operating income shows good cost management. This is important for making more money.
Confirms:Operating income is higher than $60 million in Q2 2026.
Disproves:Operating income is below $60 million in Q2 2026.
Why it matters: This guidance shows if Cognex can keep its strong revenue growth going. It will indicate how well the company is performing in its key markets.
Confirms:Q2 2026 revenue guidance confirmed at $280M or higher.
Disproves:Q2 2026 revenue guidance below $280M.
Why it matters: Growth in AI vision product sales shows Cognex's leadership in this market.
Confirms:Sales of AI vision products increase by over 20% year over year in Q2 2026.
Disproves:Sales of AI vision products grow less than 10% year over year in Q2 2026.
Why it matters: High adoption would prove Cognex's plan works and help revenue grow.
Confirms:Customer adoption rates are over 20% for new AI vision products.
Disproves:Adoption rates are below 10% for new AI vision products.
Why it matters: Reaching this target means higher profits and efficient work.
Confirms:Management says they will cut costs by $35 to $40 million each year.
Disproves:Management says they will not meet cost-cutting goals.
Why it matters: Meeting the cost reduction target helps increase margins and profits.
Confirms:Cognex achieves $35 to $40 million in annualized cost reductions by the end of 2026.
Disproves:Cost reductions fall short of the $35 million target by the end of 2026.
Why it matters: This margin guidance shows if Cognex can keep making more money. Higher margins mean better cost control.
Confirms:The adjusted EBITDA margin is set at 28% or more.
Disproves:The adjusted EBITDA margin is less than 28%.
Why it matters: Completing this program shows Cognex's commitment to returning value to shareholders. It can also signal confidence in future cash flows.
Confirms:Cognex completes the $500M share repurchase program.
Disproves:Cognex announces a pause or reduction in the share repurchase program.
